BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 4037825)

  • 41. Skin cancer after PUVA treatment for psoriasis.
    Morgan RW
    N Engl J Med; 1979 Sep; 301(10):554. PubMed ID: 460312
    [No Abstract]   [Full Text] [Related]  

  • 42. Potential ocular complications from PUVA therapy and their prevention.
    Lerman S; Megaw J; Willis I
    J Invest Dermatol; 1980 Apr; 74(4):197-9. PubMed ID: 7373073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?].
    Wollina U; Schulze M; Schaarschmidt H; Barta U; Pfeiffer L; Knopf B; Horn A
    Z Hautkr; 1985 Mar; 60(6):527-30. PubMed ID: 2581382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B in psoriasis: a comparison of clinical outcome and effect on circulating T-helper and T-suppressor/cytotoxic cells.
    Salem SA; Barakat MA; Morcos CM
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):235-42. PubMed ID: 20831697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modifications of PUVA.
    Momtaz-T K; Fitzpatrick TB
    Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acne-like eruptions induced by PUVA-treatment.
    Nielsen EB; Thormann J
    Acta Derm Venereol; 1978; 58(4):374-5. PubMed ID: 82341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulomatous secondary syphilis coinciding with PUVA treatment in a patient with psoriasis: an apparent failure of PUVA therapy.
    Neumann HA; Berretty PJ; Faber WR
    Acta Derm Venereol; 1981; 61(1):82-5. PubMed ID: 6164228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photochemotherapy of psoriasis: risk:benefit ratios.
    Bickers DR
    J Am Acad Dermatol; 1981 Jan; 4(1):90-3. PubMed ID: 7204695
    [No Abstract]   [Full Text] [Related]  

  • 49. Dose-related visual-field defects in patients receiving PUVA therapy.
    Fenton DA; Wilkinson JD
    Lancet; 1983 May; 1(8333):1106. PubMed ID: 6133134
    [No Abstract]   [Full Text] [Related]  

  • 50. Lack of dermal changes in uninvolved skin after photochemotherapy of psoriasis: biochemical studies.
    Blumenkrantz N; Weismann K; Asboe-Hansen G
    Acta Derm Venereol; 1979; 59(2):149-51. PubMed ID: 84493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Verruciform xanthoma in a psoriatic patient under PUVA therapy.
    Yamamoto T; Katayama I; Nishioka K
    Dermatology; 1995; 191(3):254-6. PubMed ID: 8534948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of methoxsalen plus near-ultraviolet radiation or mid-ultraviolet radiation on immunologic mechanisms.
    Kripke ML
    Natl Cancer Inst Monogr; 1984 Dec; 66():247-51. PubMed ID: 6531037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transformation of myelodysplasia to acute myeloid leukaemia during psoralen photochemotherapy (PUVA) treatment of psoriasis.
    Sheehan-Dare RA; Cotterill JA; Barnard DL
    Acta Derm Venereol; 1989; 69(3):262-4. PubMed ID: 2566239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of drugs and ultraviolet rays on the development of pemphigoid].
    Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Skwarczyńska-Banyś E
    Przegl Dermatol; 1980; 67(5):641-6. PubMed ID: 7005972
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis.
    Brockmeyer NH; Frühauf S; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1998 Aug; 3(8):361-6. PubMed ID: 9707517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Psoralen ultraviolet A (PUVA) photochemotherapy plus topical corticosteroids with PUVA plus bland emollients in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Ayub Med Coll Abbottabad; 2005; 17(1):34-6. PubMed ID: 15929524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical side-effects of long-wave ultraviolet light and oral 8-methoxypsoralen in patients treated for psoriasis.
    Mackey JP
    Ir J Med Sci; 1979 Feb; 148(2):36-8. PubMed ID: 478811
    [No Abstract]   [Full Text] [Related]  

  • 59. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
    Meffert H; Andersen KE; Sönnichsen N
    Photodermatol; 1984 Aug; 1(4):191-4. PubMed ID: 6531293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Itch following photochemotherapy for psoriasis.
    Rogers S; Marks J; Shuster S
    Acta Derm Venereol; 1981; 61(2):178-80. PubMed ID: 6165204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.